Traumatic glaucoma

Summary

Traumatic glaucoma (MONDO:0001626) is a disease and 3 clinical trials. A subtype of glaucoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	traumatic glaucoma
Mondo ID	MONDO:0001626
DOID	DOID:13060
SNOMED CT	68241007
UMLS	C0339594
MedGen	573251
Is cancer (heuristic)	no

Also known as: glaucoma associated with ocular trauma

Disease family

This is a subtype of glaucoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye disorder › glaucoma › traumatic glaucoma

Related subtypes (10): glaucomatous atrophy of optic disk, hypersecretion glaucoma, aqueous misdirection, phacogenic glaucoma, angle-closure glaucoma, borderline glaucoma, steroid-induced glaucoma, open-angle glaucoma, hereditary glaucoma, secondary early-onset glaucoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01301378	Not specified	TERMINATED	Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
NCT03166566	Not specified	COMPLETED	Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
NCT05593354	Not specified	UNKNOWN	MicroPulse TLT - UK Study